Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Real-world outcomes of teclistamab in triple-exposed relapsed/refractory multiple myeloma: Brazilian single-center experience

Mariana Kerbauy, Danielle Ovigli, Newton Centuriao, Lucila Kerbauy, Ricardo Helman, Guilherme Perini, Fabio Santos, Andreza Ribeiro, Leonardo Arcuri, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 7607.

https://doi.org/10.1182/blood-2025-7607

Published: 2025

Journal Articles

Molecular risk stratification of myelodysplastic syndromes in Brazil: A cohort applying IPSS-m and taxonomic classification

Frederico Honorato, Elvira Velloso, Paulo Campregher, Juliana Rocha, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Amanda Inacio Dias dos Santos, Rodrigo Kojima, Barbara Galvão, Nelson Hamerschlak, Fabio Santos

Blood (2025) 146 (Supplement 1): 7372.

https://doi.org/10.1182/blood-2025-7372

Published: 2025

Journal Articles

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Blood (2025) 146 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2025-7066

Published: 2025

Journal Articles

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

Blood (2025) 146 (Supplement 1): 7055.

https://doi.org/10.1182/blood-2025-7055

Published: 2025

Journal Articles

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Blood (2025) 146 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2025-3673

Published: 2025

Journal Articles

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Blood (2025) 146 (Supplement 1): 5391.

https://doi.org/10.1182/blood-2025-5391

Published: 2025

Journal Articles

Machine learning ensemble models for genetic-based classification of myeloproliferative and myelodysplastic/myeloproliferative neoplasms: Comparing a multinomial vs binomial approach

Jade Zezzi Martins do Nascimento, Amanda Inácio Dias Ennes, Mariana Lorenzi Savioli, Tarcila Datoguia, Aline Nishimoto, Carolina Marques, André Américo, Luiz Gustavo Cortes, Leonardo Javier Arcuri, Paulo Campregher, Nelson Hamerschlak, Fabio Santos

Blood (2025) 146 (Supplement 1): 7868.

https://doi.org/10.1182/blood-2025-7868

Published: 2025

Journal Articles

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Blood (2025) 146 (Supplement 1): 1854.

https://doi.org/10.1182/blood-2025-1854

Published: 2025

Journal Articles

Germline predisposition in hematologic malignancies: A study of 22 cases with germline DNA

Gabriela Barbosa, Rodrigo Kojima, Luiz Gustavo Cortes, Renata Minillo, Paulo Campregher, Renata Kishimoto, Mauren dos Santos, Luiz Frederico Honorato, Fabio Santos, Nelson Hamerschlak, Elvira Velloso

Blood (2025) 146 (Supplement 1): 6748.

https://doi.org/10.1182/blood-2025-6748

Published: 2025

Journal Articles

Validation of the artificial intelligence prediction of acute leukemia tool in a Latin American retrospective cohort

Jade Zezzi Martins do Nascimento, Aline Nishimoto, Amanda Inácio Dias Ennes, Mariana Lorenzi Savioli, Eduardo Chapchap, André Américo, Tarcila Datoguia, Leonardo Javier Arcuri, Nelson Hamerschlak, Fabio Santos

Blood (2025) 146 (Supplement 1): 4362.

https://doi.org/10.1182/blood-2025-4362

Published: 2025

Journal Articles

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Blood (2025) 146 (Supplement 1): 1361.

https://doi.org/10.1182/blood-2025-1361

Published: 2025

Journal Articles

Results of the first Latin American point of care manufactured, Phase I anti- CD19 CAR-T study (CARTHIAE) for Relapsed/Refractory B-cell neoplasms

Blood (2025) 146 (Supplement 1): 2405.

https://doi.org/10.1182/blood-2025-2405

Published: 2025

Journal Articles

Do patients with classic Hodgkin's lymphoma treated with ABVD in low-middle income countries have a higher risk of neutropenia/febrile neutropenia without G-CSF support? a single-center retrospective study

Blood (2025) 146 (Supplement 1): 6338.

https://doi.org/10.1182/blood-2025-6338

Published: 2025

Journal Articles

Real-world experience with prophylactic/preemptive, and therapeutic donor lymphocyte infusion (DLI) after allogeneic hematopoietic cell transplantation: A 15 year experience of single-center Study from Latin America

Frederico Honorato, Andrea Kondo, Gabriela Candelaria, Rayane Conserva, Lana Maria Alvares dos Santos, Mariana Kerbauy, Gabriele Zamperlini Netto, Juliana Fernandes, Fabio Santos, Andreza Ribeiro, Nelson Hamerschlak, Jose Kutner, Mariana Lorenzi Savioli

Blood (2025) 146 (Supplement 1): 7806.

https://doi.org/10.1182/blood-2025-7806

Published: 2025

Journal Articles

Prophylactic and preemptive donor lymphocyte infusion (DLI) improves outcomes in refractory AML undergoing allogeneic hematopoietic cell transplantation: A single-center retrospective Study from Latin America

Frederico Honorato, Gabriela Candelaria, Andrea Kondo, Felipe Medauar, Rayane Conserva, Lana Maria Alvares dos Santos, Mariana Kerbauy, Fabio Santos, Gabriele Zamperlini Netto, Juliana Fernandes, Andreza Ribeiro, Nelson Hamerschlak, Jose Kutner, Mariana Lorenzi Savioli

Blood (2025) 146 (Supplement 1): 7801.

https://doi.org/10.1182/blood-2025-7801

Published: 2025

Journal Articles

Enhancing graft-versus-host disease prophylaxis with modern strategies in matched-sibling or unrelated donor hematopoietic cell transplantation does not lead to higher relapse rates: A systematic review and meta-analysis of 15 randomized trials

Leonardo Arcuri, Victor Natal, Andre Americo, Mariana Kerbauy, Alberto Lima, Andrés Gómez de León, Andreza Ribeiro, Vanderson Rocha, Fabio Santos, Guilherme Perini, Nelson Hamerschlak, Carla Ribeiro

Blood (2025) 146 (Supplement 1): 2475.

https://doi.org/10.1182/blood-2025-2475

Published: 2025

Journal Articles

Imatinib Treated Chronic Myelogenous Leukemia Concomitant with Multiple Myeloma. Is There a Relationship?

Jose Mauro Kutner, MD, PhD, Claudia Bley, MD, Guilherme Fleury Perini, MD, Fabio Santos, Morgani Rodrigues, MD, Andreza Alice Feitosa Ribeiro, MD, PhD, Nelson Hamerschlak

Blood (2010) 116 (21): 5005.

https://doi.org/10.1182/blood.V116.21.5005.5005

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-world outcomes of teclistamab in triple-exposed relapsed/refractory multiple myeloma: Brazilian single-center experience

Molecular risk stratification of myelodysplastic syndromes in Brazil: A cohort applying IPSS-m and taxonomic classification

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Machine learning ensemble models for genetic-based classification of myeloproliferative and myelodysplastic/myeloproliferative neoplasms: Comparing a multinomial vs binomial approach

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Germline predisposition in hematologic malignancies: A study of 22 cases with germline DNA

Validation of the artificial intelligence prediction of acute leukemia tool in a Latin American retrospective cohort

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Results of the first Latin American point of care manufactured, Phase I anti- CD19 CAR-T study (CARTHIAE) for Relapsed/Refractory B-cell neoplasms

Do patients with classic Hodgkin's lymphoma treated with ABVD in low-middle income countries have a higher risk of neutropenia/febrile neutropenia without G-CSF support? a single-center retrospective study

Real-world experience with prophylactic/preemptive, and therapeutic donor lymphocyte infusion (DLI) after allogeneic hematopoietic cell transplantation: A 15 year experience of single-center Study from Latin America

Prophylactic and preemptive donor lymphocyte infusion (DLI) improves outcomes in refractory AML undergoing allogeneic hematopoietic cell transplantation: A single-center retrospective Study from Latin America

Enhancing graft-versus-host disease prophylaxis with modern strategies in matched-sibling or unrelated donor hematopoietic cell transplantation does not lead to higher relapse rates: A systematic review and meta-analysis of 15 randomized trials

Imatinib Treated Chronic Myelogenous Leukemia Concomitant with Multiple Myeloma. Is There a Relationship?

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only